EOJOAM
STSA

E. Ohman J:or Asset Management’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

E. Ohman J:or Asset Management’s Portfolio STSA Stock Details STSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-8,000
Closed -$230K – 439
2020
Q2 		$230K Buy
+8,000
New +$185K 0.01% 382

Other funds holding STSA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

E. Ohman J:or Asset Management's STSA Position: Q3 2020 in Review

E. Ohman J:or Asset Management sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q3 2020, closing a stake of 8,000 shares — an estimated $230K sold.

E. Ohman J:or Asset Management first reported a position in STSA in Q2 2020 and held it in 1 quarter. The position peaked at $230K in Q2 2020. 46 funds tracked by Wall St. Rank hold STSA as of Q3 2020.

  • E. Ohman J:or Asset Management reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • E. Ohman J:or Asset Management sold 8,000 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q3 2020, an estimated $230K.
  • E. Ohman J:or Asset Management first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • E. Ohman J:or Asset Management's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $230K in Q2 2020.
  • 46 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q3 2020.

Based on E. Ohman J:or Asset Management's 13F filing for Q3 2020, filed 5 Apr 2024.